Minqing Wu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- RNA Interference and Gene Delivery 2
- Circular RNAs in diseases 2
- Advanced biosensing and bioanalysis techniques 2
- Oncology 8
- PARP inhibition in cancer therapy 4
- HER2/EGFR in Cancer Research 2
- Co-authors
- Xiaoming Xie (12 shared papers)Hailin Tang (11 shared papers)Xinhua Xie (10 shared papers)Laisheng Li (7 shared papers)Jiaoli Guo (7 shared papers)Lu Yang (6 shared papers)Weidong Wei (7 shared papers)Yanan Kong (6 shared papers)
- Journals
- PLoS ONE (3 papers)Cancer Letters (2 papers)Medical Oncology (2 papers)Molecular Cancer Therapeutics (2 papers)Journal of Nanoparticle Research (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Minqing Wu
18 papers receiving 723 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 359
- Geriatrics and Gerontology 63
- Molecular Biology 473
- Molecular Medicine 31
- Oncology 106
Countries citing papers authored by Minqing Wu
This map shows the geographic impact of Minqing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minqing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minqing Wu more than expected).
Fields of papers citing papers by Minqing Wu
This network shows the impact of papers produced by Minqing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minqing Wu. The network helps show where Minqing Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Minqing Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 107 | |
| 2 | 2014 | 101 | |
| 3 | 2013 | 94 | |
| 4 | 2014 | 90 | |
| 5 | 2012 | 89 | |
| 6 | 2012 | 73 | |
| 7 | 2014 | 67 | |
| 8 | 2012 | 22 | |
| 9 | 2013 | 17 | |
| 10 | 2020 | 14 | |
| 11 | 2014 | 11 | |
| 12 | 2022 | 10 | |
| 13 | 2022 | 9 | |
| 14 | 2014 | 9 | |
| 15 | 2014 | 7 | |
| 16 | 2015 | 5 | |
| 17 | 2012 | 4 | |
| 18 | 2013 | 2 | |
| 19 | 2025 | 0 | |
| 20 | 2022 | 0 |
About Minqing Wu
Minqing Wu is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Plant Science, having authored 20 papers that have together received 731 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), PARP inhibition in cancer therapy (4 papers), RNA Interference and Gene Delivery (2 papers), Circular RNAs in diseases (2 papers), HER2/EGFR in Cancer Research (2 papers), Cancer Mechanisms and Therapy (2 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Cancer Research (359 citations), Geriatrics and Gerontology (63 citations), Molecular Biology (473 citations), Molecular Medicine (31 citations) and Oncology (106 citations). Minqing Wu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xiaoming Xie, Hailin Tang, Xinhua Xie, Laisheng Li, Jiaoli Guo, Lu Yang, Weidong Wei, Yanan Kong, Jie Gao and Xiaoping Liu. Their work appears in journals such as PLoS ONE, Cancer Letters, Medical Oncology, Molecular Cancer Therapeutics and Journal of Nanoparticle Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.